GLPwatch
Mounjaro vs Victoza
Drug comparison
Last updated 2026-05-28 15:46 UTCMounjaro (tirzepatide) and Victoza (liraglutide) are both injectable medications for type 2 diabetes, but Mounjaro is made by Eli Lilly while Victoza is made by Novo Nordisk. Mounjaro is given as a once-weekly shot, while Victoza is taken once daily. Additionally, Victoza is FDA-approved to help reduce cardiovascular risk in people with type 2 diabetes, which Mounjaro is not.
AI summary of the sources below.
| Mounjaro | Victoza | |
|---|---|---|
| Active ingredient | tirzepatide | liraglutide |
| Manufacturer | eli-lilly | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes, cardiovascular risk reduction |
| Label updated | 2026-04-22 | 2023-02-06 |